Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Roy Buchanan's Stock Ratings
JMP Securities Analyst
Roy Buchanan is an analyst at JMP Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
105.9%
Smart Score
Overall Average Return Percentile
98th
Number of Ratings
81
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 10/03/2025 | CDTX | Buy Now | Cidara Therapeutics | $220.10 | -21.4% | $153 → $173 | Maintains | Market Outperform | Get Alert | |
| 09/24/2025 | ASMB | Buy Now | Assembly Biosciences | $34.00 | 11.76% | → $38 | Initiates | → Market Outperform | Get Alert | |
| 08/22/2025 | DVAX | Buy Now | Dynavax Technologies | $10.85 | 194.93% | $32 → $32 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 08/12/2025 | ENTA | Buy Now | Enanta Pharma | $14.87 | 68.12% | $24 → $25 | Maintains | Market Outperform | Get Alert | |
| 08/08/2025 | DVAX | Buy Now | Dynavax Technologies | $10.85 | 194.93% | $31 → $32 | Maintains | Market Outperform | Get Alert | |
| 08/08/2025 | CDTX | Buy Now | Cidara Therapeutics | $220.10 | -70.01% | $59 → $66 | Maintains | Market Outperform | Get Alert | |
| 06/30/2025 | CDTX | Buy Now | Cidara Therapeutics | $220.10 | -73.19% | $59 → $59 | Maintains | Market Outperform | Get Alert | |
| 06/17/2025 | PYPD | Buy Now | PolyPid | $3.96 | 253.54% | $16 → $14 | Maintains | Market Outperform | Get Alert | |
| 06/03/2025 | ENTA | Buy Now | Enanta Pharma | $14.87 | 61.4% | $23 → $24 | Maintains | Market Outperform | Get Alert | |
| 06/02/2025 | CDTX | Buy Now | Cidara Therapeutics | $220.10 | -78.65% | $47 → $47 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 05/28/2025 | CVAC | Buy Now | CureVac | $5.00 | 100% | $10 → $10 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 05/27/2025 | CDTX | Buy Now | Cidara Therapeutics | $220.10 | -78.65% | $47 → $47 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 05/14/2025 | ENTA | Buy Now | Enanta Pharma | $14.87 | 54.67% | $21 → $23 | Maintains | Market Outperform | Get Alert | |
| 05/09/2025 | CDTX | Buy Now | Cidara Therapeutics | $220.10 | -78.65% | $46 → $47 | Maintains | Market Outperform | Get Alert | |
| 05/07/2025 | DVAX | Buy Now | Dynavax Technologies | $10.85 | 185.71% | $33 → $31 | Maintains | Market Outperform | Get Alert | |
| 05/05/2025 | ANTX | Buy Now | AN2 Therapeutics | $1.10 | 81.82% | $5 → $2 | Maintains | Market Outperform | Get Alert | |
| 04/29/2025 | CDTX | Buy Now | Cidara Therapeutics | $220.10 | -79.1% | $46 → $46 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 03/26/2025 | ANTX | Buy Now | AN2 Therapeutics | $1.10 | 354.55% | $5 → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 03/14/2025 | INO | Buy Now | Inovio Pharmaceuticals | $2.27 | 692.95% | $18 → $18 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 03/12/2025 | CDTX | Buy Now | Cidara Therapeutics | $220.10 | -79.1% | → $46 | Initiates | → Market Outperform | Get Alert | |
| 02/25/2025 | ANTX | Buy Now | AN2 Therapeutics | $1.10 | 354.55% | $5 → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 02/14/2025 | CVAC | Buy Now | CureVac | $5.00 | 220% | $16 → $16 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 02/13/2025 | TPG | Buy Now | TPG | $66.74 | — | — | Reiterates | Market Perform → Market Perform | Get Alert | |
| 02/11/2025 | ESPR | Buy Now | Esperion Therapeutics | $3.78 | 5.82% | $7 → $4 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 02/11/2025 | ENTA | Buy Now | Enanta Pharma | $14.87 | 41.22% | $21 → $21 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 02/03/2025 | ANTX | Buy Now | AN2 Therapeutics | $1.10 | 354.55% | $5 → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 01/30/2025 | IRWD | Buy Now | Ironwood Pharmaceuticals | $3.54 | 295.48% | $23 → $14 | Maintains | Market Outperform | Get Alert | |
| 01/23/2025 | ESPR | Buy Now | Esperion Therapeutics | $3.78 | 85.19% | $7 → $7 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 01/10/2025 | INO | Buy Now | Inovio Pharmaceuticals | $2.27 | 692.95% | $18 → $18 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 01/10/2025 | ABVX | Buy Now | Abivax | $116.02 | -71.56% | $33 → $33 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 11/26/2024 | ENTA | Buy Now | Enanta Pharma | $14.87 | 41.22% | $22 → $21 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 11/21/2024 | HOOK | Buy Now | HOOKIPA Pharma | $0.88 | 694.1% | $24 → $7 | Maintains | Market Outperform | Get Alert | |
| 11/19/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.10 | 354.55% | $5 → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 10/09/2024 | ENTA | Buy Now | Enanta Pharma | $14.87 | 47.95% | $22 → $22 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 10/01/2024 | GRTS | Buy Now | Gritstone Bio | — | — | — | Downgrade | Market Outperform → Market Perform | Get Alert | |
| 09/27/2024 | ENTA | Buy Now | Enanta Pharma | $14.87 | 47.95% | $22 → $22 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 09/16/2024 | CVAC | Buy Now | CureVac | $5.00 | 220% | $16 → $16 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 08/16/2024 | CVAC | Buy Now | CureVac | $5.00 | 220% | $18 → $16 | Maintains | Market Outperform | Get Alert | |
| 08/09/2024 | HOOK | Buy Now | HOOKIPA Pharma | $0.88 | 2622.63% | $23 → $24 | Maintains | Market Outperform | Get Alert | |
| 08/09/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.10 | 172.73% | $6 → $3 | Maintains | Market Outperform | Get Alert | |
| 08/05/2024 | GRTS | Buy Now | Gritstone Bio | — | — | $5 → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 08/02/2024 | ABUS | Buy Now | Arbutus Biopharma | $4.86 | 2.88% | $4 → $5 | Maintains | Market Outperform | Get Alert | |
| 07/03/2024 | CVAC | Buy Now | CureVac | $5.00 | 260% | $18 → $18 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 06/14/2024 | GRTS | Buy Now | Gritstone Bio | — | — | $5 → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 05/07/2024 | ENTA | Buy Now | Enanta Pharma | $14.87 | 47.95% | $23 → $22 | Maintains | Market Outperform | Get Alert | |
| 04/04/2024 | ABUS | Buy Now | Arbutus Biopharma | $4.86 | -17.7% | $4 → $4 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 04/02/2024 | GRTS | Buy Now | Gritstone Bio | — | — | $4 → $5 | Maintains | Market Outperform | Get Alert | |
| 04/02/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.10 | 445.45% | → $6 | Upgrade | Market Perform → Market Outperform | Get Alert | |
| 02/28/2024 | GRTS | Buy Now | Gritstone Bio | — | — | → $4 | Initiates | → Market Outperform | Get Alert | |
| 02/12/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.10 | — | — | Downgrade | Market Outperform → Market Perform | Get Alert | |
| 01/04/2024 | INO | Buy Now | Inovio Pharmaceuticals | $2.27 | -55.95% | → $1 | Initiates | → Market Outperform | Get Alert | |
| 01/04/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.10 | 2627.27% | → $30 | Initiates | → Market Outperform | Get Alert | |
| 11/21/2023 | ENTA | Buy Now | Enanta Pharma | $14.87 | 54.67% | $42 → $23 | Maintains | Outperform | Get Alert | |
| 11/03/2023 | DVAX | Buy Now | Dynavax Technologies | $10.85 | 148.85% | $25 → $27 | Maintains | Market Outperform | Get Alert | |
| 08/08/2023 | ENTA | Buy Now | Enanta Pharma | $14.87 | 182.45% | $65 → $42 | Maintains | Market Outperform | Get Alert | |
| 08/04/2023 | DVAX | Buy Now | Dynavax Technologies | $10.85 | 130.41% | $24 → $25 | Maintains | Outperform | Get Alert | |
| 07/18/2023 | PRDS | Buy Now | Pardes Biosciences | — | — | — | Downgrade | Market Outperform → Market Perform | Get Alert | |
| 07/06/2023 | ABUS | Buy Now | Arbutus Biopharma | $4.86 | 23.46% | → $6 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 05/09/2023 | ENTA | Buy Now | Enanta Pharma | $14.87 | 337.12% | $82 → $65 | Maintains | Outperform | Get Alert | |
| 05/03/2023 | DVAX | Buy Now | Dynavax Technologies | $10.85 | 121.2% | $25 → $24 | Maintains | Outperform | Get Alert | |
| 04/26/2023 | CVAC | Buy Now | CureVac | $5.00 | 380% | $34 → $24 | Maintains | Outperform | Get Alert | |
| 03/29/2023 | ABUS | Buy Now | Arbutus Biopharma | $4.86 | 23.46% | → $6 | Reiterates | → Market Outperform | Get Alert | |
| 03/15/2023 | PRDS | Buy Now | Pardes Biosciences | — | — | $9 → $5 | Maintains | Market Outperform | Get Alert | |
| 03/06/2023 | ESPR | Buy Now | Esperion Therapeutics | $3.78 | 296.83% | → $15 | Reiterates | → Market Outperform | Get Alert | |
| 03/03/2023 | ARGX | Buy Now | argenx | $844.00 | -46.92% | $443 → $448 | Maintains | Market Outperform | Get Alert | |
| 03/01/2023 | CRMD | Buy Now | Cormedix | $11.41 | 40.28% | $14 → $16 | Maintains | Market Perform | Get Alert | |
| 02/24/2023 | DVAX | Buy Now | Dynavax Technologies | $10.85 | 130.41% | $22 → $25 | Maintains | Market Outperform | Get Alert | |
| 02/16/2023 | IBIO | Buy Now | iBio | $1.85 | — | — | Downgrade | Market Outperform → Market Perform | Get Alert | |
| 12/13/2022 | PRDS | Buy Now | Pardes Biosciences | — | — | → $9 | Initiates | → Market Outperform | Get Alert | |
| 11/17/2022 | CVAC | Buy Now | CureVac | $5.00 | 580% | $37 → $34 | Maintains | Market Outperform | Get Alert | |
| 09/27/2022 | DVAX | Buy Now | Dynavax Technologies | $10.85 | 102.76% | → $22 | Initiates | → Market Outperform | Get Alert | |
| 08/09/2022 | ENTA | Buy Now | Enanta Pharma | $14.87 | 821.32% | $103 → $137 | Maintains | Market Outperform | Get Alert | |
| 06/28/2022 | ABUS | Buy Now | Arbutus Biopharma | $4.86 | 85.19% | $10 → $9 | Maintains | Market Outperform | Get Alert | |
| 05/19/2022 | ENTA | Buy Now | Enanta Pharma | $14.87 | 592.67% | $114 → $103 | Maintains | Market Outperform | Get Alert | |
| 05/10/2022 | ENTA | Buy Now | Enanta Pharma | $14.87 | 666.64% | $116 → $114 | Maintains | Market Outperform | Get Alert | |
| 04/22/2022 | CVAC | Buy Now | CureVac | $5.00 | 640% | $52 → $37 | Maintains | Market Outperform | Get Alert | |
| 01/18/2022 | CVAC | Buy Now | CureVac | $5.00 | 940% | → $52 | Initiates | → Market Outperform | Get Alert | |
| 12/21/2021 | ARGX | Buy Now | argenx | $844.00 | -50.47% | $368 → $418 | Maintains | Market Outperform | Get Alert | |
| 11/29/2021 | IBIO | Buy Now | iBio | $1.85 | -18.92% | → $1.5 | Initiates | → Outperform | Get Alert | |
| 09/14/2021 | PYPD | Buy Now | PolyPid | $3.96 | 253.54% | → $14 | Initiates | → Market Outperform | Get Alert | |
| 08/06/2021 | ENTA | Buy Now | Enanta Pharma | $14.87 | 417.82% | $70 → $77 | Maintains | Market Outperform | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved